毒力
微生物学
生物
细菌胶囊
细菌
肺炎链球菌
血清型
巨噬细胞
吞噬作用
败血症
病毒学
免疫学
作者
Haoran An,Chenyun Qian,Yijia Huang,Jing Li,Xianbin Tian,Jiaying Feng,Jiao Hu,Yujie Fang,Fangfang Jiao,Yuna Zeng,Xueting Huang,Xianbin Meng,Xue Liu,Xin Lin,Zhutian Zeng,Martin Guilliams,Alain Beschin,Yongwen Chen,Yuzhang Wu,Jing Wang
摘要
Many encapsulated bacteria use capsules to cause invasive diseases. However, it remains largely unknown how the capsules enhance bacterial virulence under in vivo infection conditions. Here we show that the capsules primarily target the liver to enhance bacterial survival at the onset of blood-borne infections. In a mouse sepsis model, the capsules enabled human pathogens Streptococcus pneumoniae and Escherichia coli to circumvent the recognition of liver-resident macrophage Kupffer cells (KCs) in a capsular serotype-dependent manner. In contrast to effective capture of acapsular bacteria by KCs, the encapsulated bacteria are partially (low-virulence types) or completely (high-virulence types) "untouchable" for KCs. We finally identified the asialoglycoprotein receptor (ASGR) as the first known capsule receptor on KCs to recognize the low-virulence serotype-7F and -14 pneumococcal capsules. Our data identify the molecular interplay between the capsules and KCs as a master controller of the fate and virulence of encapsulated bacteria, and suggest that the interplay is targetable for therapeutic control of septic infections.
科研通智能强力驱动
Strongly Powered by AbleSci AI